|Articles|June 5, 2013
The Data Can Speak for Itself
Applied Clinical Trials Editorial talks with CluePoints' Founder Marc Buyse about the history of CluePoints as well as the role of biostatistics in clinical trials
Advertisement
In this interview Applied Clinical Trials Editorial Director Lisa Henderson talks with CluePoints' Founder Marc Buyse. They discuss the history of CluePoints as well as the role of biostatistics: "The Data Can Speak for Itself
SPOTLIGHT EVENT
Cambridge, MassachusettsDownload Brochure
RELATED
-
- Risk-Based Approach to Monitoring
- Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?More in Risk-Based Monitoring
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building Broader Investigator Networks to Advance Global Breast Cancer Research
2
AI Offers New Pathways to Strengthen Site Leadership in Underserved Regions
3
dashClinical: Real-Time Participant Payments
4
ACT Brief: AI Partnerships, Global Trial Access, and a New Option for Menopause Symptoms
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
